TSX Delisting Review – Acerus Pharmaceuticals Corporation (ASP, ASP.WT)

March 9, 2020
Issuer: Acerus Pharmaceuticals Corporation (the "Company")
Securities: Common shares Common share purchase warrants
Symbol(s): ASP ASP.WT
Delisting Review Status: TSX has determined that the Company has regained compliance with the requirements for continued listing.
Additional Information: Please refer to TSX Bulletin #2020-0101 dated February 13, 2020.
TSX contact: Chris Birkett, Director, Toronto Stock Exchange.